These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 15902528)
21. Homocysteine: an activity marker in Behçet's disease? Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219 [TBL] [Abstract][Full Text] [Related]
22. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
23. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. Adam B; Calikoglu E J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143 [TBL] [Abstract][Full Text] [Related]
24. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis? Pay S; Musabak U; Simsek I; Erdem H; Pekel A; Sengul A; Dinc A Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S21-6. PubMed ID: 17949547 [TBL] [Abstract][Full Text] [Related]
25. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters. Sarıyıldız MA; Yazmalar L; Batmaz İ; Alpaycı M; Burkan YK; Sula B; Kaplan İ; Yıldız M; Akar ZA; Bozkurt M Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990 [TBL] [Abstract][Full Text] [Related]
26. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein. Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703 [TBL] [Abstract][Full Text] [Related]
27. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease. Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151 [TBL] [Abstract][Full Text] [Related]
29. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity. Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550 [TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease. Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411 [TBL] [Abstract][Full Text] [Related]
31. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955 [TBL] [Abstract][Full Text] [Related]
32. Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Kiraz S; Ertenli I; Calgüneri M; Oztürk MA; Haznedaroglu IC; Altun B; Erman M; Celik I Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S25-9. PubMed ID: 11760394 [TBL] [Abstract][Full Text] [Related]
33. Increased serum interleukin-32 levels in patients with Behçet's disease. Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461 [TBL] [Abstract][Full Text] [Related]
34. Vitamin D modulates peripheral immunity in patients with Behçet's disease. Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571 [TBL] [Abstract][Full Text] [Related]
35. The importance of serum interleukin-20 levels in patients with Behçet's disease. Enecik ME; Mavi B; Yücel Ç; Keskin G; Yıldız M Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054 [TBL] [Abstract][Full Text] [Related]
36. Increased plasma adrenomedullin levels in patients with Behçet's disease. Evereklioglu C; Yurekli M; Er H; Ozbek E; Hazneci E; Cekmen M; Inaloz HS Dermatology; 2000; 201(4):312-5. PubMed ID: 11146340 [TBL] [Abstract][Full Text] [Related]
38. Effect of plasma from patients with Behçet's disease on the production of nitric oxide in cultured human umbilical vein endothelial cells. Orem A; Ertürk M; Cimşit G; Kural BV Med Princ Pract; 2004; 13(1):35-8. PubMed ID: 14657617 [TBL] [Abstract][Full Text] [Related]
39. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease. Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553 [TBL] [Abstract][Full Text] [Related]
40. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations. Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]